(Q56751555)

1

0 references

Derek Weycker

2

0 references

Carlo Albera

3

0 references

Williamson Z. Bradford

4

0 references

Alex Kartashov

6

0 references

Talmadge E. King

7

0 references

Lisa Lancaster

8

0 references

Paul W. Noble

9

0 references

Steven A. Sahn

10

0 references

Michiel Thomeer

11

0 references

Dominique Valeyre

12

0 references

Athol U. Wells

American Journal of Respiratory and Critical Care Medicine

13

0 references

language of work or name

English

0 references

publication date

15 December 2011

0 references

published in

0 references

volume

184

0 references

issue

12

0 references

page(s)

1382-1389

0 references

cites work

Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Clinical course and prediction of survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Pirfenidone in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Physiology is a stronger predictor of survival than pathology in fibrotic interstitial pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Ascertainment of individual risk of mortality for patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Methods to explain the clinical significance of health status measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Determination of the clinical importance of study results

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Commentary--goodbye M(C)ID! Hello MID, where do you come from?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Assessment of health-related quality of life in patients with interstitial lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Separating gains and losses in health when calculating the minimum important difference for mapped utility measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

What is the relationship between the minimally important difference and health state utility values? The case of the SF-6D

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC

Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.201105-0840OC